SCHEDULE: RA Capital Discloses 5.8% Stake in DBV Technologies

RA Capital Management, along with affiliated entities, has reported a beneficial ownership of 5.8% in DBV Technologies, holding over 18.2 million ordinary shares.

Summary

• RA Capital Management, L.P., Peter Kolchinsky, Rajeev Shah, and RA Capital Healthcare Fund, L.P. have jointly filed a Schedule 13G.
• The filing indicates a beneficial ownership of 18,288,220 ordinary shares of DBV Technologies S.A., representing 5.8% of the class.
• This ownership stake is held through American Depositary Shares (ADSs), where each ADS represents five ordinary shares.
• The reporting persons state they are not acting as a group and disclaim beneficial ownership beyond determining their Section 13(d) obligations.
• The filing is dated July 30, 2026, with the report date being August 6, 2026.

Sentiment

Score: 6

Explanation: StockSavvy.ai views this filing as neutral to slightly positive, as it details a significant beneficial ownership stake by RA Capital Management, indicating investor confidence, but does not present new operational or financial performance data.

Positives

• Significant investment by RA Capital Management, a known healthcare-focused investment firm, suggests potential confidence in DBV Technologies' long-term prospects.
• The 5.8% stake represents a substantial position, indicating a notable level of investor interest.

Negatives

• The filing is a Schedule 13G, which is an informational filing and does not contain new operational or financial performance data.
• The reporting persons disclaim beneficial ownership beyond their Section 13(d) obligations, which may indicate a passive investment stance rather than an intent to influence control.

Risks

• The filing does not explicitly mention any risks, as it is primarily a disclosure of ownership.

Future Outlook

This filing does not contain forward-looking statements or guidance. It is a disclosure of beneficial ownership.

Management Comments

• The Reporting Persons expressly disclaim status as a 'group' for purposes of this Schedule 13G.
• RA Capital serves as investment adviser for the Fund and may be deemed a beneficial owner... of any securities of the Issuer held by the Fund.
• The Fund has delegated to RA Capital the sole power to vote and the sole power to dispose of all securities held in the Fund's portfolio...
• Because the Fund has divested voting and investment power over the reported securities it holds and may not revoke that delegation on less than 61 days' notice, the Fund disclaims beneficial ownership of the securities it holds for purposes of Section 13(d) of the Act.
• As managers of RA Capital, Dr. Kolchinsky and Mr. Shah may be deemed beneficial owners... of any securities of the Issuer beneficially owned by RA Capital.
• RA Capital, Dr. Kolchinsky, and Mr. Shah disclaim beneficial ownership of the securities reported in this Schedule 13G other than for the purpose of determining their obligations under Section 13(d) of the Act, and the filing of this Schedule 13G shall not be deemed an admission that either RA Capital, Dr. Kolchinsky, or Mr. Shah is the beneficial owner of such securities for any other purpose.

Industry Context

StockSavvy.ai notes that significant stake disclosures by investment firms like RA Capital Management are common in the biotechnology and pharmaceutical sectors, often signaling active interest or a belief in the company's development pipeline or market position.

Stakeholder Impact

• Shareholders: The disclosure of a significant stake by a prominent investment firm may be viewed positively, potentially increasing investor confidence.
• Management: May face increased scrutiny or engagement from RA Capital Management regarding company strategy and performance.

Next Steps

• The reporting persons will continue to monitor their investment in DBV Technologies S.A.

Key Dates

Keywords

DBV Technologies, RA Capital Management, Schedule 13G, Beneficial Ownership, Ordinary Shares, American Depositary Shares, Healthcare Fund, Investment